The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma

The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death. Sorafenib is approved by the U.S. Food and Drug Administration to be a first-line chemotherapy agent for patients with advanced HCC. A portion of advanced HCC patients can benefit from the treatment with sorafeni...

Full description

Bibliographic Details
Main Authors: Xinyao Hu, Hua Zhu, Yang Shen, Xiaoyu Zhang, Xiaoqin He, Ximing Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
sorafenib resistance
microRNA
long non-coding RNA
circular RNA
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.696705/full

Similar Items

Similar Items